Dr. Karavasili Christina graduated from the School of Pharmacy at Aristotle University of Thessaloniki (A.U.TH.), where she earned her M.Pharm and PhD in Pharmaceutical Technology. She began her postdoctoral research at A.U.TH. in 2019, later joining the Massachusetts Institute of Technology (MIT) as a postdoctoral researcher from 2021 to 2024. She is a recipient of doctoral research scholarships from the Fulbright foundation (Harvard medical School, MIT) and the Onassis foundation (A.U.TH.). She recently joined the School of Pharmacy (A.U.TH.) as Assistant Professor at the division of Pharmaceutical Technology.

Her research group is adopting non-invasive approaches that:

• control drug release kinetics through stimuli-responsive ^{[1,2,3,4, 5]} or biodegradable systems ^[6,7,8],
• enhance drug solubility in body fluids ^{[9,10,11,12,13]} and/or drug absorption across mucosal surfaces ^{[13,14,15,16,17]},
• prolong drug retention at the site of action ^{[18,19,20,21,22]} and
• facilitate improved patient adherence by developing easy-to-administer dosage forms for sensitive patient groups (pediatric, geriatric) ^{[23,24,25,26]} and devising drug consolidation approaches.^[27,28]

Her research includes extensive use of ex vivo tissue models (animal/human) to better simulate the biological environment and predict the in vivo performance of the developed drug delivery systems and devices. Her group is also interested in knowledge-sourcing from nature-inspired materials and processes for a wide range of biomedical applications.